Taken together, the results from animal studies tend to characterize PAPP‐A as a pregnancy-dependent oncogene in vivo, underscoring that diminished PAPP-A levels confer protective measures against aggressive BC initiation and progression. This evidence concerns the gene PAPPA and breast cancer.